Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How's that goldmine working out? Thank god I sold at .0385 because this stock will never get there again. A couple of mid-70s "inventors" coupled with partners who have committed previous stock fraud. A fool and his money soon do part.
That’s hilarious. They couldn’t sell stock at $0.005 a year ago to raise any money. Wait a year for the OTC to forget and re-hype the 1 product that will never sell, and re-file to sell stock at more than 10X’s that using the same fairy tale. Sell stock, pay themselves a handsome wage, lather, rinse, repeat.
If you knew the stock they do this every year, things have to be kept current.
Who's paying .03 at the .02 buffet?
Tom will amend the price just like he's done with all the previous offerings or he'll withdraw
the offering and continue to pawn the RMSL title for .005 on the dollar to the note sharks.
You forgot to mention the price of 3 cents, which is way higher than previous filing.
Nice $8.7mil offering after hours. Totally random timing.
I have nothing but time. Let’s go $RMSL, we’re all in on you.
It does not cost that much to actual file, please fact check before posting;
FDA 510(k) Device Review User Fee – $3,108 or $12,432 (2021)
The FDA charges to review the entire 510(k) application, the product, and the business that is applying for the FDA 510(k) clearance approval. There are two rates for the device review; $3,108 for any business that sold less than $100 million in the last tax year, and $12,432 for any business that sells more than $100 million in the last tax year
The company doesnt have the money to file a 510K with FDA. It can cost millions to get one done and on top of that a reg A done on OTC is almost certainly going to end up in dilution especially with a a/s of 3 Billion. I was really hoping this company would pull through but I not convinced anymore. Debt isnt helpful either. I could be wrong but I have drastically reduced the amount of pinks im in. Not trying to piss anyone off but I dont see it. Maybe someone can tell me what I am missing?
Nowhere did it say the 510k is filed.
Nowhere did it say the process restarted.
The tests were completed in February.
The enlisted ETC to help with the submission.
It was already submitted.
Could be 2-3 months, could be 2-3 week either way it'll happen.
Could be any day too.
GLTA
Bon voyage to the sinking SS SCAMSL.
Forms don't cause 6 year FDA delays. Bad products and bad management do.
There is something critically flawed with the product and the management to have spent hundreds of thousands of dollars and touted imminent FDA clearance over six years and still no FDA cleared product.
Anyone who believes hiring a third party to file some forms is going to solve those issues and pop out an FDA 510k in a few months is living in the bottom depths of delusion.
The PR is straight forward. The new company will help them complete the form to meet FDA requirement. The new company has a high success rate with providing similar service. RMSL is frustrated with the FDA asking for additional information and they are turning to the experts for help.
It will take another 2 to 3 months to get an approval with the new company taking over. Just relax and be patient. Good luck to All!
Why are the PRs so difficult to "interpret"?
It should be pretty simple. It's been filed or it hasn't.
Why would any CEO make it so difficult for the shareholders who are footing the bill for the expenses
to figure out if the 510k for the flagship product upon which they are basing their investment has been filed or not?
Smoke and mirrors.
The way I read the PR, is that the 510k was probably submitted and FDA continue to have questions with the filing. This new company has probably reviewed the filing and has agreed to take over the continued filing process with the FDA.
Pretty sure they must be happy with what they see, as they would not want to risk their 100% success rate.
Lots of patented products collecting dust.
Patents have zip to do with FDA approval.
They haven't filed the 510k.
The bio tests were pre-FDA 510k filing. It's right there in the RMSL timeline PR.
Pumpers don't like facts and would rather mislead other rookies into bad investments to lose money but there are folks who are objective and appreciate facts and rational information.
Total BS. Look at their PR drop history.
Even the most brain dead newbie understands that good news gets dropped for all to see in the morning and bad news is dropped after hours hoping to defray the impact.
Tom dropped this bomb and ran away in his typical fashion.
companies release PR 24/7 , I have tickers that dropped PR at 3 AM. Timing of this PR has no bearing on the content of it .
Red herring to keep shareholders at bay. The only thing this company can do is file paperwork. They can't make the design pass the muster with the FDA.
Total sham and anyone who is trying to push this as good news is doing damage to gullible rookie investors.
Sure...hence the late night PR bomb drop.
That is a confirmation the 510k was submitted. ETC is making sure the submission is accepted and approved. They will take over managing the process. Stop the false narrative.
Years and another RS before 510k approval.
3rd party straw man to keep shareholder's off Tom's back while he dilutes the company into oblivion.
What kind of a real company can't get their own product approved by the FDA after six years and then needs to bring in someone else to do the job. What is this company supposed to do? Re-design the product?
Total disaster.
InvestmentLongGone after epic 510k approval wait.
Confirmation the 510k hasn't been filed.
https://www.newmediawire.com/news/remsleep-510k-5271376
REMSLEEP HOLDINGS, INC. ENGAGES NEW REGULATORY AGENCY
Tampa, FL, June 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC:RMSL) (the "Company") announces the company has engaged Empirical Technologies Corp to complete its 510K process. Remsleep has become frustrated with the progress of its 510K submission. Partnering with ETC will ensure the Remsleep 510K submission will be streamlined and put the company's 510K submission on the right track. Remsleep plans to engage ETC with all future regulatory needs. 510K submissions through ETC have record of approval 20% to 40% faster than the industry average. ETC has a 100% success rate with filing 510K's, which gives the company confidence with the submission.
Remsleep received patent approval of its utility patent application April 2021.
The company is poised to launch marketing program as soon as 510k clearance is complete. The company continues to work on new product and expects to release future product with far greater ease and timely manner.
You gave up on a goldmine. Mark my words. ??
This stock is going to zero. I owned 1.6 million shares for way too long and luckily I was able to get out with a profit. Treat this as a service announcement. I don't care if you disagree with me because I know what I know and mark my word.
Sell your shares.
Would be insider trading if we knew now, wouldn’t it? ??
Many of us are holding big. ??
A great number of us have been accumulating for the near future FDA decision on DeltaWave. ??
Yes certainly seems that way, some decent buys today.
Welcome home! Tom's waiting with the hot cocoa!
Frequent 510k updates Tom promised?
https://www.globenewswire.com/news-release/2020/11/19/2130417/0/en/REMSleep-Holdings-Time-Line-Update.html
This is how newbie accounts get killed.
Debt conversion (convertible notes) is the very definition of dilution. OS increase is the black and white evidence of dilution.
Can't be too lazy to learn about convertible notes and the dilutive effect they have on your investment or you will pay for it eventually.
Is the float locked yet????
A/S raise just filed end of November!
It means they don't have to file to raise the AS, Still 526M OS not 2.8B
RMSL
Share Structure
Market Cap 11,313,935 05/21/2021
Authorized Shares 3,000,000,000 05/07/2021
Outstanding Shares 526,229,517 05/07/2021
Restricted 54,929,546 05/07/2021
Unrestricted 471,299,971 05/07/2021
Held at DTC Not Available
Tom's a regular Willy Wonka!
3 Billion A/S means everlasting shares!
Followers
|
312
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31338
|
Created
|
11/14/08
|
Type
|
Free
|
Moderators |
REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.
INDUSTRY
Medical Equipment & Supplies
CONTACT INFO
2202 N. WEST SHORE BLVD SUITE 200
TAMPA, FL
33607
United States
+1.912.5902001
https://www.remsleep.com/EXECUTIVE LEADERSHIP
Russell Finlay Bird
Chairman of the Board
Thomas J. Wood
Chief Executive Officer, Director
Jonathan B Lane
Chief Technology Officer, Vice President
https://www.fundable.com/remsleep
Share Structure
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |